Bone is a common site for metastases formation, particularly tumours that originate in breast tissue. Early-stage detection of bone metastases is challenging and, once established, the disease is virtually incurable. This highlights the urgent need to develop new approaches for clinical management of the disease. Unfortunately, efforts towards this have been hampered by the lack of suitable animal models that recapitulate human bone metastasis. To address this challenge, Dietmar W. Hutmacher and colleagues have now developed a humanised xenograft mouse model of breast-cancer-induced bone metastasis. They seeded biodegradable composite scaffolds with human bone-forming cells and implanted the construct together with an osteoinductive growth factor, creating a viable ‘organ’ bone in mice. After injection with human breast cancer cells, metastases were detected in the humanised bone. Thus, the study establishes a unique in vivo model that mimics human breast cancer metastasis to a human-bone-like environment, providing a tool for exploring bone metastasis and evaluating potential therapies. Page 299
A humanised xenograft mouse model for studying bone metastasis Open Access
A humanised xenograft mouse model for studying bone metastasis. Dis Model Mech 1 February 2014; 7 (2): e201. doi:
Download citation file:
Advertisement
Cited by
Call for papers – In Vitro Models of Human Disease to Inform Mechanism and Drug Discovery

We invite you to submit your latest research to our upcoming special issue: In Vitro Models of Human Disease to Inform Mechanism and Drug Discovery, coordinated by DMM Editor Vivian Li (The Francis Crick Institute, London, UK), alongside Guest Editors Austin Smith (University of Exeter, UK) and Joseph Wu (Stanford University School of Medicine, USA).The deadline for submitting articles is 6 October 2025.
The Company of Biologists Workshops

For the last 15 years, our publisher, The Company of Biologists, has provided an apt environment to inspire biology and support biologists through our Workshops series. Read about the evolution of the Workshop series and revisit JEB's experience with hosting the first Global South Workshop.
Read & Publish Open Access publishing: what authors say

We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Fast & Fair peer review

Our sister journal Biology Open has recently launched the next phase of their Fast & Fair peer review initiative: offering high-quality peer review within 7 working days. To learn more about BiO’s progress and future plans, read the Editorial by Daniel Gorelick, or visit the Fast & Fair peer review page.
Propose a new Workshop for 2027

We are currently seeking proposals for Workshops to be held in 2027. As one of the scientific organisers of a The Company of Biologists Workshop, your involvement will be focused on interdisciplinary, cutting-edge science and promoting new partnerships and collaborations. We focus on the logistics. Are you thinking about proposing a topic for one of our Workshops? Apply by Friday 30 May 2025.
Other journals from
The Company of Biologists